Metformin and/or Clomiphene Do Not Adversely Affect Liver or Renal Function in Women with Polycystic Ovary Syndrome

CONTEXT: Nonalcoholic fatty liver disease is common to insulin-resistant states such as polycystic ovary syndrome (PCOS). Metformin (MET) is often used to treat PCOS but information is limited as to its effects on liver function. OBJECTIVE: We sought to determine the effects of MET on serum hepatic...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Aubuchon, Mira, Kunselman, Allen R., Schlaff, William D., Diamond, Michael P., Coutifaris, Christos, Carson, Sandra A., Steinkampf, Michael P., Carr, Bruce R., McGovern, Peter G., Cataldo, Nicholas A., Gosman, Gabriella G., Nestler, John E., Myers, Evan R., Legro, Richard S.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Endocrine Society 2011
Gaiak:
JCEM Online: Brief Reports
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3200244/
https://ncbi.nlm.nih.gov/pubmed/21832111
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jc.2011-1093
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak